In re HIV Antitrust Litigation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA San Francisco Division PETER STALEY, et al., Case No. 19-cv-02573-EMC (LB)

Plaintiffs,

DISCOVERY ORDER

v. Re: ECF No. 1332 GILEAD SCIENCES, INC., et al., Defendants. 16 INTRODUCTION The parties dispute whether Gilead must produce its March 2021 collaboration agreement with Merck (i.e., the Gilead-Merck Agreement) regarding certain long-acting HIV treatments.1 The court denies the plaintiffs’ request to compel the production of the Gilead-Merck Agreement. Local Rule 37-3 provides that motions to compel discovery must be filed within seven days after the discovery cut-off. The fact discovery cut-off date was December 17, 2021, and the plaintiffs have not established good cause to be excused from the usual deadline. 24 25 26 27 1 Joint Disc. Letter – ECF No. 1332 at 2. Citations refer to material in the Electronic Case File (ECF); STATEMENT The end-payor plaintiffs…